JRPIM
VRTX icon

Journey Retirement Planning & Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Journey Retirement Planning & Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
2,412
-143
-6% -$63.4K 0.93% 19
2026
Q1 		$1.14M Sell
2,555
-7,337
-74% -$3.42M 1% 20
2025
Q4 		$4.48M Buy
+9,892
New +$4.26M 0.92% 20

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Journey Retirement Planning & Investment Management's VRTX Position: Q2 2026 in Review

Journey Retirement Planning & Investment Management reduced its Vertex Pharmaceuticals (VRTX) stake by 5.6% in Q2 2026, selling an estimated $63.4K and leaving 2,412 shares worth $1.2M. The position accounts for 0.93% of the portfolio, ranked #19.

Journey Retirement Planning & Investment Management first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.48M in Q4 2025. 1,014 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Journey Retirement Planning & Investment Management held 2,412 shares of Vertex Pharmaceuticals worth $1.2M as of Q2 2026.
  • Journey Retirement Planning & Investment Management sold 143 Vertex Pharmaceuticals shares in Q2 2026, an estimated $63.4K.
  • Vertex Pharmaceuticals made up 0.93% of Journey Retirement Planning & Investment Management's portfolio in Q2 2026, its #19 holding.
  • Journey Retirement Planning & Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Journey Retirement Planning & Investment Management's Vertex Pharmaceuticals position peaked at $4.48M in Q4 2025.
  • 1,014 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Journey Retirement Planning & Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.